Hits:1175 , posted at 2022/6/30 13:45

Since the establishment of CSBio, we are honored to receive the recognition from many scholars and have made many scientific achievements with CSBio products. November 7, 2019，Mohini Guleria, Tapas Das , Jeyachitra Amirdhanayagam , Haladhar D. Sarma, Ashutosh Dash, Several researchers have published the following article：Preparation of [177Lu]Lu-DOTA-Ahx-Lys40-Exendin-4 for radiotherapy of insulinoma: a detailed insight into the radiochemical intricacies using CS9243 DOTA-Ahx-Lys40-Exendin(DOTA-Exendin-4) from CSBio.